Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility.
Ϫ levels did not substantially alter kidney infection susceptibility between wild-type and Car2 Ϫ/Ϫ mice; thus, factors other than acid-base status are responsible. Car2 Ϫ/Ϫ mice had significantly increased neutrophil-gelatinase-associated lipocalin mRNA and protein and expression at baseline and a marked decreased ability to upregulate key bacterial response genes during pyelonephritis. Our findings provide in vivo evidence that supports a role for carbonic anhydrase 2 and intercalated cells in promoting renal bacterial clearance. Decreased carbonic anhydrase expression results in increased antimicrobial peptide production by cells other than renal intercalated cells, which is not sufficient to prevent infection after a bacterial challenge.
acid-base; intercalated cells; urinary tract infection; inflammation ACID-BASE REGULATION is increasingly linked to immune function. Systemic acidosis may impair immune function, antimicrobial peptides have impaired function at extreme urine pH ranges, and intercalated cells (ICs) that regulate kidney acidbase transport are increasingly recognized as innate immune effectors.
The carbonic anhydrase gene family encodes distinct isozymes that differ in tissue-specific expression and cellular localization (40) . Carbonic anhydrases are involved in H ϩ secretion, HCO 3 Ϫ reabsorption, bone resorption, and gastric acidity (40) . Carbonic anhydrase 2 (gene: Car2; protein: CA-II) is found in many tissues, including the kidney, bone, brain, eye, stomach, intestine, liver, pancreas, red blood cells, salivary glands, and uterus (30) . CA-II is highly expressed in renal ICs (4, 12) . Lower CA-II levels of expression are present in collecting duct principal cells (PCs), the loop of Henle, and proximal tubules (3, 5) . Mice that lack CA-II have metabolic acidosis, a high urine pH, and are severely depleted in kidney ICs compared with wild-type mice (4) .
During an ascending pyelonephritis, pathogens initially encounter the collecting tubule. The collecting tubule contains ICs and PCs. PCs mediate Na ϩ and water transport, and ICs regulate acid-base transport (20, 38) . Escalating evidence shows that IC function as innate immunity effectors in addition to their traditional role in the maintenance of acid-base homeostasis. We (42) have previously characterized ribonuclease 7, a potent antimicrobial peptide with a broad range of activity against uropathogens in the human kidney. Renal ribonuclease 7 expression is limited to ICs, constitutively expressed at baseline, upregulated in response to infection, and secreted into the urine (42, 43) . ICs have been demonstrated to express other innate immune proteins, including neutrophil gelatinase-associated lipocalin, also known as lipocalin 2 (gene: Lcn2; protein: Ngal), IL-18 (gene: Il18), and human ␣-defensin 5 (15, 28, 41) . Additionally, uropathogenic Escherichia coli (UPEC) preferentially adhere to the luminal surface of medullary ICs (10) . ICs are ideally positioned to defend the kidney from ascending urinary tract infections (UTIs) and activate systemic inflammatory responses (42, 43) .
Based on their phenotype of metabolic acidosis, impaired urine acidification, and IC depletion, we hypothesized that CA-II has a critical role in the innate defense of the kidney. The objective of the present study was to evaluate the functional consequences of CA-II depletion on the innate immune response during experimental murine pyelonephritis.
METHODS
Mice. The Institutional Animal Care and Use Committee of the Nationwide Children's Hospital approved murine research protocol AR12-00035. All animal experiments adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Car2-deficient (Car2 Ϫ/Ϫ ) mouse embryos and wild-type (Car2 ϩ/ϩ ) C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, ME). The initial coding sequence of the Car2 gene was replaced with a LacZ marker under the direction of the Car2 promoter (25) . Heterozygous (Car2 ϩ/Ϫ ) mice were rederived on a C57BL/6 genetic background at the Transgenic Core at the Research Institute of Nationwide Children's Hospital. Homozygous Car2 Ϫ/Ϫ mice were obtained by crossing Car2 ϩ/Ϫ mice. Car2 ϩ/ϩ littermates were used as controls. For mouse growth experiments, Car2 ϩ/Ϫ control mice were also used. The mouse genotype was determined by PCR using tail DNA using the following primer sequences: Car2 wild-type forward primer, 5=-ATGAAGGCTGAACTTAAATC-3=; Car2 mutant forward primer, 5=-TCCACATACACTTCATTCTC-3=, and common reverse primer, 5=-AGGCCTGAGTATTCATTATC-3=.
Infection. UPEC strain CFT073 was used to infect mice. CFT073 was grown statically in Luria broth (LB) medium overnight at 37°C. Bacteria were pelleted and resuspended in PBS. Female mice aged 7-10 wk were infected by inoculating 1 ϫ 10 8 CFT073 in 50 l PBS transurethrally. A second inoculum was performed 3 h later, as previously described (45) . Twenty-four hours after the first infection, kidneys and bladders were harvested. Kidneys were homogenized in a bullet blender (Next Advance, Averill Park, NY). The bacterial burden was determined by plating serial dilutions of kidney or bladder homogenates on the LB plate. If UTI confirmation was needed for a PCR experiment, kidneys were bisected longitudinally. Infection was confirmed as half of the kidney, and the other longitudinal half of each kidney was processed for immunostaining or mRNA extraction. Kidney or bladder clearance of bacteria was defined as Ͻ50 colonyforming units (CFU)/tissue (44) .
Base supplementation. NaHCO 3 (100 mM/l) was added to the drinking water of mice assigned base supplementation from the time of weaning (ϳ4 wk) until euthanasia (7-10 wk) based on prior reports (32, 37) .
LacZ staining. After euthanasia, mice were perfused with PBS and periodate-lysine-paraformaldehyde (PLP) fixative (2% paraformaldehyde, 75 mM lysine, and 75 mM NaIO 4). Kidneys were bisected, fixed in cold PLP fixative for 2 h, and then soaked in 30% sucrose overnight. Kidneys and bladders were embedded in optimal cutting temperature embedding media after treatment. Frozen sections were dried at room temperature for 10 min and then fixed in PLP fixative for 10 min. Kidney slides were incubated with the LacZ substrate X-galactosidase at 4°C overnight. Slides were counterstained with nuclear fast red.
Immunostaining. After deparaffinization, rehydration, antigen retrieval, and blocking, specimens were incubated with primary antibody overnight at 4°C and incubated for 30 min at room temperature with horseradish peroxidase for immunohistochemistry or fluorophore-conjugated secondary antibody for immunofluorescence. Slides for immunohistochemistry were developed with 3,3=-diaminobenzidine and counterstained with hematoxylin. Slides for immunofluorescence were mounted in Vectashield Mounting Media with 4=,6-diamidino-2-phenylindole (Vector Laboratories, Burlinghame, CA). Imaging was performed with a Keyence BZ-9000 "all in one" microscope and camera (Keyence, Osaka, Japan). Cells were quantified with the automated "dynamic cell count" and "cell count" features of BZ-II Analyzer software (Keyence). Images were adjusted with the BZ-II Analyzer and/or a GNU image manipulation program (GNU Free Software Foundation, Boston, Massachusetts). The antibodies and fluorochromes used are shown in Table 1 .
Blood and urine analysis. Blood was collected through the submandibular vein and injected into iSTAT EC8ϩ for HCO 3 Ϫ , K ϩ , and pH measurements (Abbot Point of Care, Princeton, NJ). Urine was collected by bladder massage. Urine was transferred into 1.5-ml tubes containing corn oil. Urine pH was measured with a micro-pH electrode (Mettler Toledo, Columbus, OH). The Comparative Pathology and Mouse Phenotyping Shared Resource at The Ohio State University (Columbus, OH) performed complete blood counts and differentials.
ELISA. Murine urine Ngal levels were quantified by ELISA (catalog no. AF1857, R&D Systems) and run in duplicate. Urine creatinine levels were measured by a colorimetric assay to account for differences in urine concentration (catalog no. 500701, Cayman Chemical).
Quantitative real-time PCR. For cDNA generation, RNA was purified from kidneys using the RNeasy kit (Qiagen, Valencia, CA) and quantified with spectrometry. RNA quality/purity was also determined by the ratio of 260 to 280 nm. A value of 2.0 Ϯ 0.1 was considered to be pure. cDNA was generated using the RT First Strand kit (Qiagen) per the manufacturer's protocol.
For gene profiling, cDNA was amplified using the 7500 Real-Time PCR System (Applied Biosystems, Carlsbad, CA). The RT 2 profiler antibacterial response (catalog no. PAM148z, Qiagen) was performed according to the manufacturer's instructions. Analysis and data quality control were performed using RT 2 profiler PCR Array Data Analysis software (version 3.5, Qiagen). Only results that passed quality checks in PCR array reproducibility, RT efficiency, and genomic DNA contamination were included. Gene expression was normalized using a panel of five housekeeping genes [␤-actin (Actb), ␤2-microglobulin (B2m), Gapdh, glucuronidase-␤ (Gusb), and heat shock protein 90 kDa ␣ (cytosolic) class B member 1 (Hsp90ab1)]. Ϫ/Ϫ bladder (right). Bladder magnification: ϫ40; kidney magnification: ϫ4. 4=,6-diamidino-2-phenylindole (DAPI; blue) was used to stain nuclei in the bladder images. Statistical analysis. Statistical analysis was performed, and graphs were made with GraphPad Prism software (GraphPad Software, La Jolla, CA). For the purpose of graphs, negative kidney culture results were assigned a value of 0.1 so that all data points were represented on log-scale scatter plots; the zero value was used for statistical analysis.
Groups were analyzed for differences with a two-tailed Student's t-test. Welch's correction was used for bacterial burden analysis, as comparable SDs were not assumed. Proportions and percentages were compared using the VassarStats 2 ϫ 2 contingency table, which assigned the 2 -value, or, if the expected cell frequency was less than five, the Fisher
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exact probability test was applied (26) . Two-way ANOVA was used to measure the effects of two or more variables in weight time course data. If significant differences were identified with ANOVA, post hoc analysis with the Tukey test was used to determine which groups within the sample were different. For the mouse antibacterial response arrays, fold changes of expression between groups and treatments were calculated using SA Biosciences RT 2 profiler PCR Array Data Analysis software (11). Statistical significance was assigned for P values of Ͻ0.05, and results are expressed as means Ϯ SD.
RESULTS

The phenotype of Car2
Ϫ/Ϫ mice. To confirm CA-II deletion and phenotype as previously reported by Breton et al. (4) ϩ/ϩ mice (P ϭ 0.651, 0.447, and 0.57, respectively).
Bacterial burden and renal bacteria clearance post-UPEC inoculation. Infections were variable based on kidney laterality with mean CFU differences between left and right kidneys of 3,892 (range: 0 -109,580) in Car2 ϩ/ϩ kidneys and 60,261 (range: 0 to 2.4 ϫ 10 6 ) in Car2 Ϫ/Ϫ kidneys (n ϭ 16 mice/ genotype). Thus, individual rather than pooled kidneys were evaluated, as previously done by Tittel et al. (45) . Figure 3 shows 24-and 48-h kidney and bladder bacterial burdens along with kidney bacterial clearance. Twenty-four hours after inoculation, Car2 Ϫ/Ϫ mice had a mean bacterial burden that was 5-fold higher in the bladder and 15-fold higher in the kidneys compared with Car2 ϩ/ϩ mice. Furthermore, Car2 Ϫ/Ϫ mice were three times less likely to clear bacteria from the kidney at 24 h compared with control mice, and they were eight times less likely to clear at 48 h. Bacteria were largely retained in the bladder of both genotypes. Histological confirmation of infection in UPEC-inoculated mice was confirmed by the presence of neutrophils (Fig. 4) . Normalization of serum HCO 3 Ϫ . Because Car2 Ϫ/Ϫ had a lower serum HCO 3 Ϫ and pH than Car2 ϩ/ϩ mice (Table 2) , mouse growth, serum laboratory, and 24-h bacterial burden experiments were repeated with NaHCO 3 supplemented to Car2 Ϫ/Ϫ mice in their drinking water and compared with a control group of Car2 ϩ/ϩ mice with no base supplementation. The highest tolerable NaHCO 3 -supplemented water concentration was 100 mmol/l. Serum HCO 3 Ϫ normalized from 17 mmol/l in Car2 Ϫ/Ϫ mice to 20 mmol/l in base-supplemented Car2 Ϫ/Ϫ mice (Table 1 and Fig. 5A ). Because mean weights did not differ between Car2 ϩ/ϩ and Car2 ϩ/Ϫ mice, these genotypes were pooled for time course growth data. The growth of Car2 Ϫ/Ϫ mice with and without base supplementation was compared with that of pooled Car2 ϩ/Ϫ and Car2 ϩ/ϩ mice from 3 to 12 wk. Car2 Ϫ/Ϫ mice demonstrated improved growth with base supplementation, whereas growth was not affected in control mice (Fig. 5C) .
To analyze the effect of correction of the acid-base disturbances, we performed experimental UTI on base-supplemented Car2 Ϫ/Ϫ mice and nontreated control mice. The mean 24-h CFU was 2.4 times higher in base-supplemented Car2 Ϫ/Ϫ bladders. Compared with Car2 ϩ/ϩ mice, the mean CFU was 16.5 times higher in base-supplemented Car2 Ϫ/Ϫ kidneys (Fig.   5D ). Despite missing statistical significance, presumably because of variability in the controls, it was consistent with nonbase-supplemented Car2 Ϫ/Ϫ kidneys (Fig. 3B) . Base-supplemented Car2 Ϫ/Ϫ kidneys were six times less likely to be clear of bacteria than Car2 ϩ/ϩ kidneys (Fig. 5E ). Standardization of urine pH. Because urine pH may affect bacterial growth more than host serum acid-base status, we standardized urine pH between Car2 Ϫ/Ϫ and control mice. To standardize urine pH secondary to the relatively high baseline urine pH in Car2 Ϫ/Ϫ mice (Table 1) , control Car2 ϩ/ϩ mice had NaHCO 3 added to their drinking water, and the 24-h bacterial burden experiment was repeated (Fig. 6) . Car2 Ϫ/Ϫ mice had a mean bacterial burden that was 10.4 times higher in the bladder Ϫ/Ϫ mice except for serum chemistries, where n ϭ 11 mice/genotype; for complete blood counts and differentials, n ϭ 3 mice/genotype. *Statistically significant difference. (Fig. 7) . Genes that displayed at least a twofold change and that were statistically significantly different (P Ͻ 0.05) between infection status and genotype are shown in Table 3 (Fig. 8, I and J). In the absence of infection, urine Ngal/creatinine levels were higher in Car2 Ϫ/Ϫ mice than in Car2 ϩ/ϩ mice at 20.81 Ϯ 5.032 pg/mg (n ϭ 6) versus 10.28 Ϯ 1.393 pg/mg (n ϭ 10), respectively (P ϭ 0.026).
DISCUSSION
We have demonstrated a significant increase in kidney bacterial burden and diminished antibacterial response in Car2 Ϫ/Ϫ mice compared with Car2 ϩ/ϩ mice. We further confirmed the previous findings that Car2 Ϫ/Ϫ mice have at least a threefold decrease in the percentage of ICs. CA-II helps generates the needed H ϩ for H ϩ V-ATPase; thus, even ICs that are present should conceptually have impaired function (9) . Of note, aveolar macrophage antibacterial activity is impaired with V-ATPase inhibition, providing an example of overlap between acid-base and immune regulation (2) .
A primary component of human renal CA-II deficiency and/or IC dysfunction is distal renal tubular acidosis (dRTA). dRTA results when urinary acidification in the collecting tubule is impaired, resulting in systemic metabolic acidosis and total body K ϩ depletion (33) . Furthermore, urine pH remains inappropriately high due to the inability to secrete protons distally. Car2 Ϫ/Ϫ mice have metabolic acidosis and hypokalemia along with relatively alkaline urine, consistent with dRTA. The association of CA-II deficiency and UTI risk is supported by reports of increased UTIs in humans with dRTA. First, Halperin et al. (17) reported that "most" of 10 unrelated dRTA patients had a history of UTI. Next, children and adults with familial hypomagnesaemia-hypercalciuria, a rare condition in which dRTA is a component, had UTIs in 3 of 4 subjects (75%) and 10 of 18 subjects (55%) in case series (34, 35) . Finally, in a case series of patients with medullary sponge, a condition associated with dRTA, 14 of 21 female patients (67%) and 4 of 26 of male patients (15%) presented with bacteriuria (7, 19 
Car2
Ϫ/Ϫ mice we have identified appears consistent with our initial hypothesis that proper IC number and function is a crucial component of the innate defense of the urinary tract. Potential mechanisms for the increased UTI risk in Car2 Ϫ/Ϫ mice include an increased infection risk from metabolic acidosis, changes in bacterial growth secondary to urine pH, increased infection susceptibility due to CA-II deficiency in other organ systems, IC depletion, or abnormal renal expression of CA-II across the kidneys and urinary tract. In the present study, we attempted to address all possible mechanisms to establish the significance of CA-II and ICs in the innate defense of the kidney.
Whether altered acid-base homeostasis contributes to infection risk is controversial. Immune function is supported by increased human neutrophil activation and macrophage phagocytosis during acidosis (29, 46) . However, decreased neutrophil chemotaxis and increased infection-related hemodialysis mortality with acidosis support increased infection susceptibly (39, 47) . In the present study, we demonstrated impaired renal bacterial clearance and an approximately Ͼ15-fold increased bacterial burden in Car2 Ϫ/Ϫ compared with Car2 ϩ/ϩ kidneys with and without base supplementation. Additionally basesupplemented Car2 Ϫ/Ϫ bladders had increased bacterial burdens, despite negligible CA-II bladder expression. Thus, factors other than base supplementation or local expression of CA-II are likely responsible for the infection risk. The increase in serum HCO 3 Ϫ was biologically relevant as base supplementation did result in improved growth in Car2 Ϫ/Ϫ mice; however, this observation must be tempered as base supplementation only partially normalized the serum pH.
Alkaline urine pH from defective distal acidification is a characteristic of dRTA. Historically, acidification of urine with agents such as ascorbic acid has been proposed as a UTI treatment but has not been conclusively demonstrated to be 
B: serum pH in Car2
Ϫ/Ϫ mice partially corrected from the nonbase-supplemented mean of 7.12 Ϯ 0.03 (Table 2) . It was 7.21 Ϯ 0.05 and 7.30 Ϯ 0.07 in base-supplemented Car2 Ϫ/Ϫ and Car2 ϩ/ϩ mice, respectively (P ϭ 0.003). C: Car2 Ϫ/Ϫ mice were smaller at all time points (P Ͻ 0.0001). Base-supplemented Car2 Ϫ/Ϫ mice did exhibit significant increased growth at 11 wk (P ϭ 0.047). The growth of Car2 Ϫ/Ϫ mice with (n ϭ 10) and without (n ϭ 9) base supplementation was plotted against the pooled control group of 20 mice with (10 wild-type mice and 10 Car2 ϩ/Ϫ mice) and without (5 Car2 ϩ/ϩ mice and 15 Car2 ϩ/Ϫ mice) base supplementation. D: the mean bladder CFU was higher in base-supplemented Car2 Ϫ/Ϫ mice at 1.08 ϫ effective (16) . Furthermore, strains of uropathogens may have variable pH sensitivity (22) . Our group has demonstrated that certain urinary antimicrobial peptides can have a wide variety of activity at different urinary pHs. Specifically, activity is reduced at extremes of pH and optimum around physiologic 7.4 (48) . The host must balance altering growth conditions for bacteria while not detrimentally affecting its innate defenses.
Car2
Ϫ/Ϫ and base-supplemented Car2 ϩ/ϩ mice had similar mean pH readings, yet Car2 Ϫ/Ϫ mice had significantly higher kidney and bladder bacterial burdens. Either factors other than urine pH are responsible for the UTI susceptibility in Car2 Ϫ/Ϫ mice or the microenvironment around the collecting duct is altered by "local" pH adjustments not reflected by the overall urine pH.
Infection susceptibility due to CA-II deficiency in other organ systems is a potential mechanism for UTI risk in Car2 Ϫ/Ϫ mice. The phenotype of Car2 Ϫ/Ϫ mice has previously been reported to include impaired bone formation along with gastric cysts and pit cell hyperplasia (24, 27) . The likelihood is low that these extrarenal manifestations contribute to UTI risk. Neutrophils contain CA-I and CA-II at a 3:1 concentration; however, the similar serum neutrophil number in Car2 ϩ/ϩ and Car2 Ϫ/Ϫ mice does not suggest an inherent neutrophil deficiency in these cells (6) .
Although systemic metabolic acidosis, impaired urine acidification, and extrarenal abnormalities associated with CA-II deficiency might contribute to infection risk, our findings suggest that they are not the primary etiology of UTI risk in Car2 Ϫ/Ϫ mice. Therefore, we propose that loss of innate immune effectors produced by ICs contributes to UTI risk in Car2 Ϫ/Ϫ mice. We (42, 43) have previously demonstrated that human ICs secrete RNase 7 into the urine and that inactivation of urinary RNase 7 results in a marked increase in bacterial growth. Ideally, we would evaluate RNase7 mRNA and protein expression as a target for decreased innate immune effectors with IC deficiency. However, no known mouse ortholog of RNase 7 has been identified (36) . Car2 Ϫ/Ϫ mice have increased mRNA expression of antibacterial peptides (Lcn2) at baseline. Lcn2/Ngal has previously been demonstrated to be expressed postrenal injury by renal ICs, the loop of Henle, and, in some reports, the proximal tubule (18, 28) . Regardless of the etiology of the baseline increased Lcn2 expression in Car2 Ϫ/Ϫ mice, it is not sufficient to prevent increased infection susceptibility and is associated with a decreased ability to upregulate Lcn2 expression in response to infection.
A marked inability to upregulate the bacterial response after UPEC inoculation was identified. In addition to their antimicrobial roles, cathelicidin and Ngal have previously been demonstrated to have anti-inflammatory properties. Cathelicidin blocks dendritic cell Toll-like receptor 4 activation (13). During pneumococcal pneumonia, Ngal attenuates the inflammatory response and bacterial clearance (49) . Historically, CRP production was presumed restricted to the liver, but renal cortical epithelial cells have been identified as a second site for production (21) . CRP mediates phagocytosis; therefore, the decreased Crp expression in Car2 Ϫ/Ϫ mice is consistent with increased bacterial burden postinfection. Bacterial lipopolysaccharides induce inflammation by Cd14, Tnf, and Mefv (14, 23, 31 Renal ICs have several similarities to innate immune cells from other organs. Examples of epithelial cells with important innate immunity roles include type II pneumocytes of the lung and Paneth cells of the small intestine. ICs share common structural features with these aforementioned epithelial cells, including optimal strategic locations to prevent infection dissemination, apical microvilli, prominent endoplasmic reticulum and/or mitochrondria, and the production of innate immune proteins (1, 8) .
While our study offers an exciting new correlation between CA-II deficiency and pyelonephritis risk, we do acknowledge some limitations. First, although serum HCO 3 Ϫ in Car2
Ϫ/Ϫ mice normalized with base supplementation, the serum pH only partially corrected. Our antibacterial response PCR array evaluated whole kidney mRNA for differences between Car2 Ϫ/Ϫ and wild-type mice. Because ICs, the primary site for renal CA-II expression, only account for a small percentage of total kidney cells, significant differences may be diluted out by the overall contribution of other cells. Inflammatory infiltrates during renal function have focal differences in occurrence and intensity; thus, we often had relatively large SDs, which resulted in a marked change in fold expression between genotypes and infection status but did not reach statistical significance. It is possible that key regulatory genes with statistically nonsignificant and/or lower fold changes have considerable biological relevance. The antibacterial response arrays only evaluate for differences between 84 key genes. While these genes are important in general in response to infection, ICspecific pathways and genes may not have been captured on the arrays. Because CA-II deficiency is global, extrarenal contributions to the observed phenotype cannot be completely ruled out. An important future research direction will be the generation of conditional knockout animals in which CA-II deficiency is limited to ICs. Such model systems can be used to conclusively demonstrate whether ICs are kidney epithelial innate immune cells, similar to Paneth cells of the small intestine. Additionally, whether altered CA-II expression impairs circulating neutrophil, macrophage, or dendritic cell function warrants extensive evaluation.
In conclusion, after transurethral UPEC inoculation, Car2 Kidney Ngal (green) immunolabeling staining at baseline and during infection labeled for collecting ducts with aquaporin 2 (red). In the Car2 ϩ/ϩ cortex at baseline (A) and during infection (B), occasional proximal tubules demonstrated low immunoreactivity (arrows), but collecting ducts were negative (arrowheads). At baseline (C), no Car2 ϩ/ϩ medullary staining for Ngal was found in collecting ducts (arrowhead), but during infection (D), some collecting ducts stained for Ngal (arrows), whereas others did not (arrowheads). In Car2 Ϫ/Ϫ mice at baseline (E) and during infection (F), cortical Ngal immunoreactivity was present in occasional proximal tubules (arrows) but not collecting ducts (arrowheads). At baseline (G), some occasional Car2 inflammatory response. The findings of this study expand on the past descriptions of acid-base regulation and renal innate immunity to determine the functional immune consequences of CA-II deficiency. Car2 Ϫ/Ϫ mice had decreased IC endowment, which indicates that Car2 is important to not just acid-base homeostasis but also to proper IC development and/or function. In light of the previous data, we propose that CA-II deficiency, potentially due to IC depletion, increases pyelonephritis risk.
